08.21.26 -- Why Is Biopharma Left Out Of The U.S. Infrastructure Conversation?

See how an amorphous solid dispersion (ASD) of acalabrutinib was designed using in vitro studies and in silico modeling. Understand how ASD formulations can enhance bioavailability.

Targeted impurity identification and purification redesign dramatically improved yield, reduced process complexity, and enabled reliable API supply for Phase II clinical development.

Integrating regulatory strategy with R&D planning early in drug development helps to minimize formulation risks and align manufacturing with compliance while preventing costly delays.

Operational excellence relies on strong quality foundations that sustain speed and flexibility. Rigorous standards reduce risk, accelerate progress, and build the trust needed for lasting success.

Understanding the potential pitfalls and partnering with the right experts can make all the difference in overcoming the complexities of complex generic OSD development.

Explore the key advantages of stick-pack formats for pharmaceuticals and nutraceuticals, from enhanced product safety and cost-efficiency to improved compliance and marketability.

Uncover the role of solid form services in helping meet accelerated timelines of the drug development lifecycle along with examples of robust workflows for fast and thorough solid form screens.